Clinical Usefulness of Serum Pepsinogen II in the Management of Helicobacter pylori Infection

Publisher： Karger

E-ISSN： 1421-9867|70|3|167-172

ISSN： 0012-2823

Source： Digestion, Vol.70, Iss.3, 2005-01, pp. : 167-172

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Helicobacter pylori infection in combination with the serum pepsinogen I/II ratio and interleukin-1β-511 polymorphisms are independent risk factors for gastric cancer in Thais

By Yamada Sirikan   Matsuhisa Takeshi   Makonkawkeyoon Luksana   Chaidatch Suparp   Kato Shunji   Matsukura Norio  

Journal of Gastroenterology, Vol. 41, Iss. 12, 2006-12 ,pp. : 1169-1177

Springer Publishing Company

Access to resources Recommend Favorite

Cutoff Pepsinogen Level for Predicting Unintendedly Eradicated Cases of Helicobacter pylori Infection in Subjects with Seemingly Normal Pepsinogen Levels

By  

Digestion, Vol. 95, Iss. 3, 2017-03 ,pp. : 229-236

Karger

Access to resources Recommend Favorite

Helicobacter pylori Infection - Management from a European Perspective

By  

Digestive Diseases, Vol. 32, Iss. 3, 2014-04 ,pp. : 275-280

Karger

Access to resources Recommend Favorite

‘Rescue’ Therapies for the Management of Helicobacter pylori Infection

By  

Digestive Diseases, Vol. 24, Iss. 1-2, 2006-05 ,pp. : 113-130

Karger

Access to resources Recommend Favorite

Gastric Cancer Screening by Combined Assay for Serum Anti-Helicobacter pylori IgG Antibody and Serum Pepsinogen Levels - The ABC Method

By  

Digestion, Vol. 93, Iss. 1, 2016-0 ,pp. : 13-18

Karger

Access to resources Recommend Favorite